AIIMS warns against the use of Remdesivir, other drugs: New Delhi’s All India Institute of Medical Sciences (AIIMS) has warned against the overuse of currently popular drugs for treating Covid-19 such as Remdesivir and Tocilizumab until more evidence that establishes their efficacy is found. The doctors also said Hydroxychloroquine has failed to show any efficacy in three randomised control trials, a critical requirement in evaluating new therapies. India, however, still recommends Hydroxychloroquine to treat mild cases of Covid-19. Read more here
To read the full story, Subscribe Now at just Rs 249 a month
Already a subscriber? Log in
Subscribe To BS Premium
₹249
Renews automatically
₹1699₹1999
Opt for auto renewal and save Rs. 300 Renews automatically
₹1999
What you get on BS Premium?
- Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
- Pick your 5 favourite companies, get a daily email with all news updates on them.
- Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
- Preferential invites to Business Standard events.
- Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
Need More Information - write to us at assist@bsmail.in